Company Filing History:
1 out of 1,745 
1 out of 141 
1 out of 5,094 
Years Active: 2025
Title: Bertrand Cariou: Innovator in Allergy Treatment
Introduction
Bertrand Cariou is a notable inventor based in Nantes, France. He has made significant contributions to the field of allergy treatment, particularly in understanding the role of PCSK9 in asthma and allergic diseases. His innovative work aims to address a global health burden that affects millions.
Latest Patents
Cariou holds a patent titled "Methods and compositions for treating asthma and allergic diseases." This invention explores the implications of PCSK9 on inflammation and sepsis, focusing on its impact on allergies and asthma. Preliminary data from his research indicates that PCSK9 deficiency increases the percentage of regulatory T cells in various immune tissues. His findings suggest that inhibitors of PCSK9 could be effective in treating asthma and food allergies.
Career Highlights
Throughout his career, Bertrand Cariou has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the University of Nantes (Université De Nantes). His research has contributed to a deeper understanding of the mechanisms underlying allergic responses.
Collaborations
Cariou has collaborated with notable colleagues, including Antoine Magnan and Grégory Bouchaud. Their combined expertise has furthered research in the field of allergy treatment.
Conclusion
Bertrand Cariou's innovative work in allergy treatment highlights the importance of understanding the underlying mechanisms of diseases. His contributions pave the way for new therapeutic approaches to combat asthma and allergic conditions.